During the past decade, Sutter Cancer Centers Radiation Oncology Services-Roseville conducted 64 clinical trials. In the 10-year time frame, 64 clinical trials started and 52 clinical trials were completed, i.e. on average, 81.3% percent of trials that started reached the finish line to date. In the past 5 years, 15 clinical trials started and 39 clinical trials were completed. i.e. 260% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sutter Cancer Centers Radiation Oncology Services-Roseville" #1 sponsor was "National Cancer Institute (NCI)" with 58 trials, followed by "SWOG Cancer Research Network" with 17 trials sponsored, "Alliance for Clinical Trials in Oncology" with 14 trials sponsored, "NRG Oncology" with 12 trials sponsored and "Radiation Therapy Oncology Group" with 12 trials sponsored. Other sponsors include 12 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sutter Cancer Centers Radiation Oncology Services-Roseville" #1 collaborator was "National Cancer Institute (NCI)" with 67 trials as a collaborator, "NRG Oncology" with 31 trials as a collaborator, "Canadian Cancer Trials Group" with 8 trials as a collaborator, "Radiation Therapy Oncology Group" with 7 trials as a collaborator and "Agenus Inc." with 1 trials as a collaborator. Other collaborators include 7 different institutions and companies that were collaborators in the rest 17 trials.

According to Clinical.Site data, the most researched conditions in "Sutter Cancer Centers Radiation Oncology Services-Roseville" are "Invasive Breast Carcinoma" (6 trials), "Recurrent Ovarian Carcinoma" (6 trials), "Recurrent Squamous Cell Lung Carcinoma" (6 trials), "Cervical Adenocarcinoma" (5 trials) and "Recurrent Breast Carcinoma" (5 trials). Many other conditions were trialed in "Sutter Cancer Centers Radiation Oncology Services-Roseville" in a lesser frequency.

Most popular intervention types in "Sutter Cancer Centers Radiation Oncology Services-Roseville" are "Drug" (96 trials), "Other" (79 trials), "Biological" (50 trials), "Radiation" (44 trials) and "Procedure" (31 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (44 trials), "Quality-of-Life Assessment" (35 trials), "Paclitaxel" (18 trials), "Biospecimen Collection" (17 trials) and "Carboplatin" (17 trials). Other intervention names were less common.

The vast majority of trials in "Sutter Cancer Centers Radiation Oncology Services-Roseville" are 90 trials for "All" genders, 28 trials for "Female" genders and 7 trials for "Male" genders.

Currently, there are NaN active trials in "Sutter Cancer Centers Radiation Oncology Services-Roseville". undefined are not yet recruiting, 26 are recruiting, 69 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 20 completed trials in Sutter Cancer Centers Radiation Oncology Services-Roseville, 4 suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Sutter Cancer Centers Radiation Oncology Services-Roseville, 3 "Phase 1" clinical trials were conducted, 67 "Phase 2" clinical trials and 68 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".